Search details
1.
A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.
Oncologist
; 29(4): 350-355, 2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-38394390
2.
Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer.
Cancer Invest
; 41(5): 487-490, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37067780
3.
Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.
Int J Mol Sci
; 24(4)2023 Feb 20.
Article
in English
| MEDLINE | ID: mdl-36835649
4.
Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature.
Oncologist
; 26(8): 640-646, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33896096
5.
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma.
bioRxiv
; 2023 Dec 25.
Article
in English
| MEDLINE | ID: mdl-38234792
6.
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.
JAMA Oncol
; 9(12): 1702-1707, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37856106
7.
Oral administration of TRAIL-inducing small molecule ONC201/TIC10 prevents intestinal polyposis in the Apc min/+ mouse model.
Am J Cancer Res
; 12(5): 2118-2131, 2022.
Article
in English
| MEDLINE | ID: mdl-35693092
8.
Advances in Systemic Therapy for Gastric Cancer.
Gastrointest Endosc Clin N Am
; 31(3): 607-623, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34053641
9.
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma.
Front Pharmacol
; 12: 751568, 2021.
Article
in English
| MEDLINE | ID: mdl-34916936
10.
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors.
Clin Cancer Res
; 27(20): 5519-5527, 2021 10 15.
Article
in English
| MEDLINE | ID: mdl-34321280
11.
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects.
Cancer Manag Res
; 12: 2731-2742, 2020.
Article
in English
| MEDLINE | ID: mdl-32368150
12.
Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer: A Brown University Oncology Research Group Phase II Study (BrUOG295).
Am J Clin Oncol
; 43(12): 857-860, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32976178
13.
Neoadjuvant Treatment for Pancreatic Cancer.
Semin Oncol
; 46(1): 19-27, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30630600
14.
Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma.
Hematol Oncol Clin North Am
; 31(2): 359-375, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28340883
15.
Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
Hematol Rep
; 8(3): 6625, 2016 Sep 28.
Article
in English
| MEDLINE | ID: mdl-27781079
16.
Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations.
J Gastrointest Oncol
; 6(5): 561-9, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26487950
17.
Sustained Partial Response to Inhibition of the Mitogen-Activated Protein Kinase and Autophagy Pathways in Combination With Immune Checkpoint Blockade in KRAS-Mutated Adenocarcinoma of the Small Bowel.
JCO Precis Oncol
; 4: 1122-1127, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-35050786
18.
Spontaneous Regression and Complete Response to Immune Checkpoint Blockade in a Case of High-Grade Neuroendocrine Carcinoma.
JCO Precis Oncol
; 4: 1006-1011, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-35050766
19.
Immune checkpoint inhibitors for esophageal cancer: are we moving in the right direction?
Ann Transl Med
; 7(Suppl 3): S102, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31576309
Results
1 -
19
de 19
1
Next >
>>